Close Menu

NEW YORK ─ Hologic said on Friday that it has been awarded a $119 million contract from the US government to expand its production capacity for COVID-19 molecular tests.

The contract was awarded by the Department of Defense Joint Rapid Acquisition Cell, the Department of the Air Force's Acquisition COVID-19 Task Force, and the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA), with BARDA providing the funding.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.